Quick Ratio in % of ELITE PHARMACEUTICALS INC /NV/ from Q4 2011 to Q3 2025

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Quick Ratio history and change rate from Q4 2011 to Q3 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Quick Ratio for the quarter ending 30 Sep 2025 was 154 %, a 64.8% increase year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Quick Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 154 +60.6 +64.8% 30 Sep 2025
Q2 2025 139 +53.2 +61.7% 30 Jun 2025
Q1 2025 121 +35.9 +42.4% 31 Mar 2025
Q4 2024 112 +25.4 +29.4% 31 Dec 2024
Q3 2024 93.5 -4.07 -4.17% 30 Sep 2024
Q2 2024 86.2 -23.9 -21.7% 30 Jun 2024
Q1 2024 84.7 -32.3 -27.6% 31 Mar 2024
Q4 2023 86.5 -25.1 -22.5% 31 Dec 2023
Q3 2023 97.6 -10.1 -9.34% 30 Sep 2023
Q2 2023 110 +3.79 +3.56% 30 Jun 2023
Q1 2023 117 +13 +12.5% 31 Mar 2023
Q4 2022 112 +10.9 +10.8% 31 Dec 2022
Q3 2022 108 +19.5 +22.1% 30 Sep 2022
Q2 2022 106 +28.2 +36.1% 30 Jun 2022
Q1 2022 104 +34.8 +50.3% 31 Mar 2022
Q4 2021 101 +40.5 +67.3% 31 Dec 2021
Q3 2021 88.2 +32.1 +57.1% 30 Sep 2021
Q2 2021 78.1 +24.5 +45.8% 30 Jun 2021
Q1 2021 69.1 +17.1 +32.8% 31 Mar 2021
Q4 2020 60.2 +3.79 +6.72% 31 Dec 2020
Q3 2020 56.1 -3.18 -5.36% 30 Sep 2020
Q2 2020 53.6 -12.5 -18.9% 30 Jun 2020
Q1 2020 52.1 -20.5 -28.3% 31 Mar 2020
Q4 2019 56.4 -23.8 -29.7% 31 Dec 2019
Q3 2019 59.3 -35.3 -37.3% 30 Sep 2019
Q2 2019 66.1 -44.2 -40% 30 Jun 2019
Q1 2019 72.6 -55.5 -43.3% 31 Mar 2019
Q4 2018 80.2 -72.7 -47.5% 31 Dec 2018
Q3 2018 94.6 -63.7 -40.2% 30 Sep 2018
Q2 2018 110 -33.5 -23.3% 30 Jun 2018
Q1 2018 128 +3.68 +2.96% 31 Mar 2018
Q4 2017 153 +53.6 +54% 31 Dec 2017
Q3 2017 158 +77.1 +95% 30 Sep 2017
Q2 2017 144 +75.6 +111% 30 Jun 2017
Q1 2017 124 +60.5 +94.8% 31 Mar 2017
Q4 2016 99.2 +38 +62.1% 31 Dec 2016
Q3 2016 81.2 +18.4 +29.3% 30 Sep 2016
Q2 2016 68.2 +4.07 +6.35% 30 Jun 2016
Q1 2016 63.9 +10.6 +19.8% 31 Mar 2016
Q4 2015 61.2 +15.7 +34.5% 31 Dec 2015
Q3 2015 62.8 +34.2 +120% 30 Sep 2015
Q2 2015 64.1 +43.7 +214% 30 Jun 2015
Q1 2015 53.3 +36.1 +211% 31 Mar 2015
Q4 2014 45.5 +29.6 +186% 31 Dec 2014
Q3 2014 28.6 +10.6 +58.8% 30 Sep 2014
Q2 2014 20.5 +2.37 +13.1% 30 Jun 2014
Q1 2014 17.2 +1.43 +9.1% 31 Mar 2014
Q4 2013 15.9 +4.94 +45.1% 31 Dec 2013
Q3 2013 18 +9.6 +114% 30 Sep 2013
Q2 2013 18.1 +10.1 +126% 30 Jun 2013
Q1 2013 15.7 +7.94 +102% 31 Mar 2013
Q4 2012 11 +1.54 +16.3% 31 Dec 2012
Q3 2012 8.41 30 Sep 2012
Q2 2012 8 30 Jun 2012
Q1 2012 7.79 31 Mar 2012
Q4 2011 9.42 31 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.